-Intravenous (“IV”) CYB004 demonstrated robust and rapid-onset psychedelic effects at lower doses compared to native DMT, suggesting potential as a short-acting, scalable treatment – – Intramuscular (“IM”) dosing of SPL028 produced robust, short-duration psychedelic effects in the majority of participants – – Both IV and IM routes were safe and well-tolerated, with potential for IM…